Infectious Disease
Cabenuva, Apretude
hiv-medication-injections
Condition
Learn about long-acting, provider-prescribed injections for HIV treatment or pre-exposure prophylaxis (PrEP) at Infuse Care.
Specialty
Therapies we administer
HIV attacks CD4 immune cells. Antiretroviral therapy (ART) can lower the virus to undetectable levels, and people who keep an undetectable viral load have effectively no risk of passing HIV to a partner through sex. For some people, a long-acting injection can replace daily pills for treatment, and a separate long-acting injection is available for prevention (PrEP).
If you think you may have been exposed to HIV, contact a provider or emergency department right away. Post-exposure medicine (PEP) works best when started within 72 hours.
Long-acting injections may help some people who find daily pills hard to take consistently. Cabenuva treats HIV; Apretude helps prevent it. They have different requirements and are not interchangeable.
The most common side effects are pain, swelling or a lump at the injection site. Fever, tiredness and headache can also occur.
A negative HIV test is required before starting Apretude and before each injection. Missing an injection visit can lead to low drug levels, which may allow HIV resistance to develop. These medicines can stay in the body for a year or longer after the last dose, so talk with your provider before stopping.
Your prescribing provider decides which treatment is right for you. Infuse Care administers prescribed therapies after a referral, a clinical review and any required insurance authorization, and we keep your provider's office updated on your care.
More in this specialty
For patients
Call our team and we'll coordinate with your doctor and insurance.